On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $96.57 which represents a decrease of $-1.33 or -1.36% from the prior close of $97.9. The stock opened at $96.05 and ...

Headquartered in Foster City, California, Gilead Sciences, Inc. (GILD) is a prominent biopharmaceutical company with a market ...

On Tuesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $90.22 which represents a slight increase of $0.38 or 0.42% from the prior close of $89.84. The stock opened at ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Vertex Pharmaceuticals (VRTX). But which of these two stocks ...

Gilead Sciences (GILD) has been one of the most ... between trends in earnings estimate revisions and short-term stock price movements. Gilead is expected to post earnings of $1.62 per share ...

In the latest trading session, Gilead Sciences (GILD ... changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank ...

Wells Fargo & Company raised Gilead Sciences from an equal weight rating to an overweight rating and lifted their target price for the stock from $78.00 to $100.00 in a report on Monday.

Gilead stock surges after Q3 earnings beat estimates and raised FY 2024 guidance, with strong HIV drug sales and analyst ...

Truist Financial increased their price target on Gilead Sciences from $82.00 to $83.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Sanford C. Bernstein assumed ...

shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $85.46, changing hands for $85.83/share. When a stock reaches the target an analyst has ...